Improving lung cancer monitoring and outcomes for diverse populations
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
This study is looking to improve how we keep an eye on and support patients with early-stage lung cancer after their treatment, by gathering real-life information to help create better follow-up care recommendations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10881972 on NIH RePORTER |
What this research studies
This research focuses on enhancing lung cancer surveillance and outcomes for patients with early-stage non-small cell lung cancer (NSCLC). It aims to create a comprehensive data source that tracks real-world patterns of lung cancer surveillance and the resulting health outcomes. By analyzing this data, the project seeks to develop evidence-based recommendations for monitoring patients after curative treatment. The research will utilize existing infrastructure from a clinical research consortium that serves multiple states, ensuring a diverse population is represented.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage non-small cell lung cancer who have undergone curative-intent therapy.
Not a fit: Patients with advanced-stage lung cancer or those who have not received curative treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring strategies that enhance survival rates and quality of life for lung cancer patients.
How similar studies have performed: While there is ongoing research in lung cancer surveillance, this project aims to fill a significant gap in understanding real-world outcomes, making it a novel approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Braithwaite, Dejana K — University of Florida
- Study coordinator: Braithwaite, Dejana K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.